Latest HHSE Audits, Form 10 SEC Reporting Updates

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
Latest HHSE Audits, Form 10 SEC Reporting Updates







Blog: OTC Status, Audits, Distributions, "The Lion Prince" 







------------------------------------------------------------------- ---------------------------------------------------------------- 







Hannover House (HHSE) Investor Relations Blog 


Thursday May 9, 2013 

Updates on a Variety of Things... 

Good Afternoon HHSE Friends & Shareholders - As requested, listed below are some items not covered in the Board of Directors meeting as posted today on the OTC Markets site. 


1). Status of "Yield" Sign on OTC Markets -- 
The Company has fully complied with the disclosure filings for "Current Reporting" status, but is missing the Attorney's Letter stating as much. The Securities Attorney that will be posting this letter is currently working on the Corporate Financing documents listed in the Board of Directors Minutes, so it will be a couple of more days before the Attorney Letter is posted (at which time, our designation should return to "Current" / Fully Reporting Pinksheet status).

2. Status of Audits -- 
We've had a very positive development with respect to completing the 2011 and 2012 audits (note, that we have moved the covered years to reflect "the two most recent, full year periods" as required under EDGAR rules). Suffice it to say that our biggest obstacle in providing satisfactory support for H-T has been resolved to satisfaction. We will not "forecast" the release date of the audits (and the simultaneous filing of the Form 10 Registration Statement with the S.E.C., which is otherwise already completed); we'll just do it, then say, "Aha! Go check it out!"

3. Distribution Ventures / Pacts and Personnel -- 
The Company has mentioned that there is a venture being structured under which Hannover House would form a "multi-studio distribution pact" with two (or three) other independent suppliers. The goal of such a combined marketing presence would be to lower our cost-of-sales, while increasing our unit-sales penetration and customer base. The determination of the value of such a pact was long-in-the-process, and based in large part by management's dissatisfaction with the placement rates being achieved by outside sales representatives. One of these outside, commissioned-sales representatives, Tony Perez, has since accepted a full-time position with Origin Films. In 2011, Mr. Perez licensed his library of horror films and urban features to Hannover House (which 36 titles the Company has not yet started marketing), and subsequently worked as a commissioned, non-exclusive sales representative for the Company. We wish Mr. Perez well, and hope that his new employment with Origin generates mutually satisfactory results. Under the new Hannover House (multi-studio) distribution venture, there is no more opportunity for commissioned, outside or non-exclusive sales representatives. In respect of the confidentiality of the multi-studio distribution pact at this time (one of the other three primary studios is also publicly-traded), the formal announcement of this sales venture will be withheld until possibly as late as August (which is the first month during which "new release" shipments will be handled under the new mutli-studio distribution pact). 

4. The Lion Prince -- 
Can't contain our enthusiasm for the acquisition of this amazing, $20-million dollar live-action / African wilderness adventure. The stars (two, young African children) are outstanding, and the story and message in the film is inspiring. Hannover House is looking at various release date opportunities, but has initial sites set for late January, 2014 (to be "on retail shelves" during February's Black History Month). Stay tuned! 




------------------- -----------------------




Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 50

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 235

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 0

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Florida Homebuyers: Navigating Flood Zone Risks Smartly

Updated Category News Views 92

Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 61

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 37

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
Lazard Closes Deal with Campbell, Launches Lazard CL

Updated Category News Views 59

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 91

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 72

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading

Top 5 Most Recently Viewed Articles

ATYR Stock Investors: Important Class Action Update

Updated Category News Views 139

Key Information for ATYR Pharma Shareholders ATYR Pharma, Inc. has recently faced significant challenges that have caught the attention of its shareholders. Investors who have purchased shares of ATYR during the specified class period are encouraged to stay informed about the ongoing legal developments. Engaging with The Gross Law Firm can provide shareholders with the...

Continue Reading
Zymeworks Stock Target Steady After Positive Trial Results

Updated Category News Views 89

Zymeworks Keeps Stock Rating Steady After ESMO 2024 Results Zymeworks Inc. (NASDAQ: ZYME) has maintained its stock rating and price target after revealing encouraging results from its recent cancer treatment clinical trials at a significant medical conference. The ratings firm H.C. Wainwright has reiterated a Neutral rating and set a price target of $10.00 per share...

Continue Reading
Exploring New Opportunities in Convertible Bonds with BMAX ETF

Updated Category News Views 253

Introduction to the New ETF A recently introduced exchange-traded fund (ETF), known as the REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX), is gaining attention for its focus on convertible bonds from companies that have Bitcoin included in their financial strategies. This ETF began trading recently and represents a growing trend in the investment landscape....

Continue Reading
iBio Secures Strategic Investments to Propel Biotech Advancements

Updated Category News Views 140

iBio's Strategic Investment Announcement iBio, Inc. (NYSE: IBIO), a pioneer in AI-driven antibody immunotherapies, has made an impactful stride in its mission, announcing the successful closure of a private investment offering totaling over $650,000 from its Board of Directors and corporate officers. This investment is a significant vote of confidence in iBio's strategy...

Continue Reading
Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Updated Category News Views 111

Simulmedia Appoints Jonathan Steuer as Chief Scientist Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and...

Continue Reading